Ahmed M Metwaly Selected Research

Doxorubicin (Adriamycin)

10/2021	Discovery of new anticancer thiourea-azetidine hybrids: design, synthesis, in vitro antiproliferative, SAR, in silico molecular docking against VEGFR-2, ADMET, toxicity, and DFT studies.
1/2021	Discovery of new quinoxaline-2(1H)-one-based anticancer agents targeting VEGFR-2 as inhibitors: Design, synthesis, and anti-proliferative evaluation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ahmed M Metwaly Research Topics

Disease

28	Neoplasms (Cancer) 03/2024 - 08/2017
8	COVID-19 10/2023 - 01/2021
2	Human Influenza (Influenza) 01/2024 - 01/2023
1	Staphylococcal Infections 01/2024
1	Virus Diseases (Viral Diseases) 01/2024
1	Ascites 11/2023
1	Breast Neoplasms (Breast Cancer) 11/2023
1	Carcinoma (Carcinomatosis) 11/2023
1	Triple Negative Breast Neoplasms 05/2023
1	Influenza in Birds (Avian Flu) 01/2023
1	Infections 01/2023
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2023
1	Hepatocellular Carcinoma (Hepatoma) 01/2021
1	Poisoning 10/2020
1	Type 2 Diabetes Mellitus (MODY) 07/2019
1	Liver Neoplasms (Liver Cancer) 08/2017
1	Diabetes Mellitus 01/2017

Drug/Important Bio-Agent (IBA)

21	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 03/2024 - 01/2020
6	Peptide Hydrolases (Proteases)FDA Link 09/2022 - 01/2021
5	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2021
4	Sorafenib (BAY 43-9006)FDA Link 03/2024 - 01/2021
4	pyrimidineIBA 11/2023 - 01/2023
3	TheobromineIBA 12/2023 - 05/2023
2	AlkaloidsIBA 01/2024 - 12/2023
2	PhytochemicalsIBA 01/2024 - 01/2023
2	Caspase 9IBA 10/2023 - 01/2023
2	PyrimidinesIBA 10/2023 - 01/2023
2	PapainIBA 09/2022 - 02/2022
2	LigandsIBA 03/2022 - 02/2022
2	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2021 - 01/2021
1	patuletinIBA 01/2024
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2024
1	Pilocarpine (Ocusert)FDA LinkGeneric 01/2024
1	Atropine FDA LinkGeneric 01/2024
1	Colchicine FDA LinkGeneric 01/2024
1	ThiadiazolesIBA 12/2023
1	AntioxidantsIBA 11/2023
1	2,2'- azino- di- (3- ethylbenzothiazoline)- 6- sulfonic acid (ABTS)IBA 11/2023
1	XanthineIBA 11/2023
1	RNA-Dependent RNA Polymerase (RNA Dependent RNA Polymerase)IBA 10/2023
1	benzamideIBA 10/2023
1	Caspase 8 (Caspase-8)IBA 10/2023
1	Antineoplastic Agents (Antineoplastics)IBA 07/2023
1	compound 18IBA 07/2023
1	Estradiol (Delestrogen)FDA LinkGeneric 01/2023
1	Phytoestrogens (Phytoestrogen)IBA 01/2023
1	GlucosidesIBA 01/2023
1	GlycosidesIBA 01/2023
1	Hemagglutinins (Hemagglutinin)IBA 01/2023
1	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2023
1	gamma-sitosterol (beta-sitosterol)IBA 01/2023
1	Protons (Proton)IBA 01/2023
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2023
1	Neuraminidase (Sialidase)IBA 01/2023
1	ErbB Receptors (EGF Receptor)IBA 01/2023
1	Tyrosine Kinase InhibitorsIBA 01/2023
1	Caspase 3 (Caspase-3)IBA 01/2023
1	Niacinamide (Nicotinamide)FDA LinkGeneric 12/2022
1	pyridineIBA 11/2022
1	thiangazoleIBA 09/2022
1	arctigeninIBA 09/2022
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 06/2022
1	SARS-CoV-2 3C-like proteinaseIBA 06/2022
1	Antiviral Agents (Antivirals)IBA 06/2022
1	StreptovaricinIBA 06/2022
1	luteoside CIBA 06/2022
1	coumarinIBA 03/2022
1	EnzymesIBA 02/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021
1	Glycoproteins (Glycoprotein)IBA 01/2021
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 01/2021
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2021
1	PhosphoproteinsIBA 01/2021
1	trioctyl phosphine oxide (TOPO)IBA 10/2020
1	SilverIBA 08/2017
1	SaponinsIBA 08/2017
1	PPAR gammaIBA 01/2017
1	Sulfonylurea ReceptorsIBA 01/2017

Therapy/Procedure

1	Therapeutics 10/2023
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 07/2019